4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Personalized Cardiology and Precision Medicine
Personalized cardiology and precision medicine are revolutionizing heart disease treatment by tailoring care to each individual based on their unique genetic makeup, lifestyle, and environment. This approach allows cardiologists to select the most effective therapies for patients, increasing the likelihood of successful outcomes and minimizing adverse effects. By utilizing advanced diagnostic tools, such as genetic testing and imaging, personalized cardiology helps identify risk factors early, enabling timely interventions. In the realm of precision medicine, therapies are designed to target specific pathways involved in the patient’s condition, ensuring more efficient treatment and improving the overall prognosis for heart disease patients.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom